SCHEMBL21363675

SCHEMBL21363675

C=CCc1cc2c(cc1OCCCl)OCO2

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.44
MAPT P10636 2/20 0.44
CYP1A2 P05177 1/20 0.44
POLB P06746 2/20 0.43
ALDH1A1 P00352 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ALOX15 P16050 1/20 0.39
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAOB P27338 1/20 0.34
PTGDR Q13258 1/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRB2 P47870 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14193612 0.85 CYP3A4 (0.44) CYP3A4MAPTCYP1A2POLBALDH1A1
SCHEMBL4843039 0.84 POLB (0.48) CYP3A4MAPTCYP1A2POLBALDH1A1
SCHEMBL4846051 0.81 POLB (0.43) CYP3A4MAPTCYP1A2POLBALDH1A1
SCHEMBL4849521 0.80 ALDH1A1 (0.43) CYP3A4MAPTCYP1A2POLBALDH1A1
SCHEMBL14552371 0.78 POLB (0.61) CYP3A4MAPTCYP1A2POLBALDH1A1
SCHEMBL21363608 0.76 CYP3A4 (0.49) CYP3A4MAPTCYP1A2POLBALDH1A1
SCHEMBL21363758 0.75 CYP3A4 (0.63) CYP3A4MAPTCYP1A2ALDH1A1SMN1; SMN2
SCHEMBL14552348 0.75 MAOB (0.54) CYP3A4MAPTCYP1A2POLBALDH1A1
SCHEMBL30262896 0.75 POLB (0.43) CYP3A4MAPTCYP1A2POLBALDH1A1
SCHEMBL21363612 0.75 HPGD (0.44) CYP3A4MAPTCYP1A2ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019175712-A1 NEW USES FOR CATECHOL MOLECULES AS INHIBITORS TO GLUTATHIONE S-TRANSFERASE METABOLIC PATHWAYS BASF CORPORATION (US) 2019-09-19 WO disclosed
WO-2019175713-A1 NEW CATECHOL MOLECULES AND THEIR USE AS INHIBITORS TO P450 RELATED METABOLIC PATHWAYS BASF CORPORATION (US) 2019-09-19 WO disclosed